MEDICATION USE IN PEDIATRIC PATIENTS WITH COVID-19 HOSPITALIZED IN A REFERRAL HOSPITAL IN LIMA, PERU, 2020-2022

Título traducido de la contribución: USO DE MEDICAMENTOS EN PACIENTES PEDIÁTRICOS CON COVID-19 HOSPITALIZADOS EN UN HOSPITAL DE REFERENCIA DE LIMA, PERÚ, 2020 – 2022

Medalit Luna-Vilchez, Jhonatan R. Mejia, Zhamanda N. Ortiz-Benique, Mitsi Santiago-Abal, Alvaro Taype-Rondan

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

Resumen

This study aimed to describe the use of medication in pediatric patients with COVID-19 hospitalized at the National Children’s Health Institute-San Borja (INSN-SB) in Lima, Peru, between March 2020 and March 2022. Therefore, we conducted a descriptive, observational study to evaluate the use of six medications: corticosteroids, ceftriaxone, azithromycin, immunoglobulin, hydroxychloroquine, and ivermectin. We compared the results among subpopulations defined according to the COVID-19 pandemic waves. We included 421 pediatric patients. Corticosteroids were prescribed to 40.4%, ceftriaxone to 35.6%, azithromycin to 12.1%, immunoglobulin to 3.6%, hydroxychloroquine to 2.4%, and ivermectin to 0.5% of the patients. The use of ceftriaxone and azithromycin was less frequent during the third wave. Hydroxy-chloroquine was used almost exclusively during the first wave. Only patients with pediatric multisystem inflammatory syndrome used immunoglobulin. Overall, the prescription of the evaluated medications decreased during the third wave.

Título traducido de la contribuciónUSO DE MEDICAMENTOS EN PACIENTES PEDIÁTRICOS CON COVID-19 HOSPITALIZADOS EN UN HOSPITAL DE REFERENCIA DE LIMA, PERÚ, 2020 – 2022
Idioma originalInglés
Páginas (desde-hasta)73-78
Número de páginas6
PublicaciónRevista Peruana de Medicina Experimental y Salud Publica
Volumen40
N.º1
DOI
EstadoPublicada - 2023

Palabras clave

  • children
  • COVID-19
  • drugs
  • Peru (source: MeSH NLM)

Huella

Profundice en los temas de investigación de 'USO DE MEDICAMENTOS EN PACIENTES PEDIÁTRICOS CON COVID-19 HOSPITALIZADOS EN UN HOSPITAL DE REFERENCIA DE LIMA, PERÚ, 2020 – 2022'. En conjunto forman una huella única.

Citar esto